BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29921218)

  • 1. A comparison of LKB1/AMPK/mTOR metabolic axis response to global ischaemia in brain, heart, liver and kidney in a rat model of cardiac arrest.
    Majd S; Power JHT; Chataway TK; Grantham HJM
    BMC Cell Biol; 2018 Jun; 19(1):7. PubMed ID: 29921218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice.
    Wang Y; Zhu S; Liu H; Wei W; Tu Y; Chen C; Song J; Li J; Sun S; Wang C; Xu Z
    Dis Markers; 2019; 2019():7420196. PubMed ID: 31929843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early glycogen synthase kinase-3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway.
    Majd S; Power JH; Koblar SA; Grantham HJ
    Eur J Neurosci; 2016 Aug; 44(3):1987-97. PubMed ID: 27177932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1.
    Sakamoto K; Zarrinpashneh E; Budas GR; Pouleur AC; Dutta A; Prescott AR; Vanoverschelde JL; Ashworth A; Jovanović A; Alessi DR; Bertrand L
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E780-8. PubMed ID: 16332922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR remains unchanged in diet-resistant (DR) rats despite impaired LKB1/AMPK cascade in adipose tissue.
    Han J; Liang H; Tian D; Du J; Wang Q; Xi P; Wang H; Li Y
    Biochem Biophys Res Commun; 2016 Aug; 476(4):333-339. PubMed ID: 27235551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis.
    Jung TY; Ryu JE; Jang MM; Lee SY; Jin GR; Kim CW; Lee CY; Kim H; Kim E; Park S; Lee S; Lee C; Kim W; Kim T; Lee SY; Ju BG; Kim HS
    Exp Mol Med; 2020 Nov; 52(11):1831-1844. PubMed ID: 33219302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK is a direct adenylate charge-regulated protein kinase.
    Oakhill JS; Steel R; Chen ZP; Scott JW; Ling N; Tam S; Kemp BE
    Science; 2011 Jun; 332(6036):1433-5. PubMed ID: 21680840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone activates rat liver adenosine 5,-monophosphate-activated protein kinase: relation to CaMKKb, TAK1 and LKB1 expression and energy status.
    Vargas R; Ortega Y; Bozo V; Andrade M; Minuzzi G; Cornejo P; Fernandez V; Videla LA
    J Biol Regul Homeost Agents; 2013; 27(4):989-99. PubMed ID: 24382180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lipid peroxidation product 4-hydroxy-trans-2-nonenal causes protein synthesis in cardiac myocytes via activated mTORC1-p70S6K-RPS6 signaling.
    Calamaras TD; Lee C; Lan F; Ido Y; Siwik DA; Colucci WS
    Free Radic Biol Med; 2015 May; 82():137-46. PubMed ID: 25617592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway.
    Hsu JL; Liu SP; Lee CC; Hsu LC; Ho YF; Huang HS; Guh JH
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Oct; 387(10):979-90. PubMed ID: 25005758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Far-Infrared Irradiation Decreases Proliferation in Basal and PDGF-Stimulated VSMCs Through AMPK-Mediated Inhibition of mTOR/p70S6K Signaling Axis.
    Hwang YJ; Park JH; Cho DH
    J Korean Med Sci; 2023 Oct; 38(41):e335. PubMed ID: 37873631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ox-Lp(a) transiently induces HUVEC autophagy via an ROS-dependent PAPR-1-LKB1-AMPK-mTOR pathway.
    Li GH; Lin XL; Zhang H; Li S; He XL; Zhang K; Peng J; Tang YL; Zeng JF; Zhao Y; Ma XF; Lei JJ; Wang R; Wei DH; Jiang ZS; Wang Z
    Atherosclerosis; 2015 Nov; 243(1):223-35. PubMed ID: 26407666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPK Causes Cell Cycle Arrest in LKB1-Deficient Cells via Activation of CAMKK2.
    Fogarty S; Ross FA; Vara Ciruelos D; Gray A; Gowans GJ; Hardie DG
    Mol Cancer Res; 2016 Aug; 14(8):683-95. PubMed ID: 27141100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Shenzhu Tiaopi granule on hepatic insulin resistance in diabetic Goto-Kakizakirats via liver kinase B1/adenosine 5'-monophosphate/mammalian target of rapamycin signaling pathway.
    Yin Y; Fang Z; Wu Y; You L
    J Tradit Chin Med; 2021 Feb; 41(1):107-116. PubMed ID: 33522203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
    Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
    J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells.
    Dong LX; Sun LL; Zhang X; Pan L; Lian LJ; Chen Z; Zhong DS
    Acta Pharmacol Sin; 2013 Feb; 34(2):314-8. PubMed ID: 23178462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
    Shaw RJ
    Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis.
    Hwang YJ; Park JH; Cho DH
    J Korean Med Sci; 2020 Sep; 35(35):e289. PubMed ID: 32893519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK.
    Zhang CS; Hawley SA; Zong Y; Li M; Wang Z; Gray A; Ma T; Cui J; Feng JW; Zhu M; Wu YQ; Li TY; Ye Z; Lin SY; Yin H; Piao HL; Hardie DG; Lin SC
    Nature; 2017 Aug; 548(7665):112-116. PubMed ID: 28723898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.